Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5783_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
40 Мб
Скачать
8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
151
8.4.1 Cerebral Autoregulation (CA)
Cerebral autoregulation (CA) is dened as the ability of the cerebrovascular system to maintain relative constant CBF despite changes in cerebral perfusion pressure [17]. Thus, cerebral autoregulation is dened as a pressure phenomenon. The major­ity of autoregulatory control occurs at the level of the cerebral arterioles. Arterioles will constrict and dilate in response to increases and decreases in cerebral perfusion pressure, respectively, to maintain constant CBF between a cerebral perfusion pres­sure (CPP) of 50–150mmHg [18]. CBF outside of these ranges becomes dependent upon the perfusion pressure. A signicant proportion of vascular resistance, how­ever, is also mediated at the level of the small arteries. Alterations in sympathetic tone of these pial arteries can shift the autoregulatory curve upward or downward [19] (Fig.8.3).
The theoretical mechanisms by which CBF is maintained over a wide range of perfusion pressures are quite extensive and beyond the scope of this review. Briey, however, hypothesized mechanisms can be grouped into myogenic, metabolic, and neurogenic categories. The myogenic theory postulates that smooth muscle cells of the arteries and arterioles constrict or dilate in response to changes in transmural pressure generated across the vessel wall [20]. This may be mediated through altera­tions in the position of the actin-myosin laments in these smooth muscles [21].
Passive collapse
75
50
25
Cerebral Blood Flow (ml/100 g/min)
25
Vasodiatory
Cascade Zone
50 75 75
VASCULARCALIBER
Cerebral Perfusion Pressure (mm Hg)
Zone of Normal
Autoregulation
100125 150
Autoregulation
Breakthrough Zone
60
40
ICP (mm Hg)
20
Fig. 8.3 Dark line representing the autoregulatory curve. Note CBF matches CPP at the extremes of the curve. The lighter line represents cerebral blood volume and the above vessels refer to the state of patency at varying cerebral perfusion pressures. (Rose and Mayer [18])
152
The metabolic theory postulates that local changes in cerebral blood ow release a variety of substances that both affect vessel diameter and couple ow with metabo­lism [22]. The neurogenic theory suggests that small intrinsic nerves may be respon­sible for changes in CBF [23].
E. M. Manno and F. Sorond
8.4.2 CO2 Vasoreactivity
Unlike cerebral autoregulation which is a pressure phenomenon, CO2 vasoreactivity is a metabolic phenomenon. There is a direct increase in CBF with increasing PaCO2 [24, 25]. The response curve of CBF to Pa CO2 is sigmoidal with the CBF response attening below 15–20mmHg and above 100mmHg (Fig.8.3). PaCO2 will freely diffuse across the blood–brain barrier; however, changes in CBF are mediated through changes in cerebral spinal uid (CSF) hydrogen ion concentration. These changes, however, are short-lived as the choroid plexus of the brain will equilibrate and buffer these changes over a few hours [26] returning CBF to its baseline level. Cerebrovascular reserve is a terminology that is used to dene the amount of ow during maximal arteriolar dilation. It is described as a percentage of maximal dilation [27].
8.5 TCD/TCCS: Assessment ofCerebral Autoregulation
andCO
Vasoreactivity
2
The assessment of cerebral autoregulation and CO2 vasoreactivity requires continu­ous monitoring of TCD/TCCS ow velocities during manipulations of blood pres­sure and CO2, respectively. Technically, this is achieved through the use of a head holder that locks down the probes during insonation of bilateral ow velocities in the vessels of interest.
Cerebral autoregulation can be evaluated under dynamic or static conditions. Dynamic testing involves an induced drop in blood pressure or spontaneous blood pressure oscillations during continuous TCD monitoring. Induced changes are often performed during rapid deation of thigh blood pressure cuffs. The abrupt drop in blood pressure leads to a mirrored drop in TCD ow velocities. In patients with poor autoregulation, TCD ow velocities will parallel a slow return in blood pressure. In patients with intact autoregulation, TCD/TCCS ow velocities will return to base­line immediately and will precede improvements in blood pressure. A similar type of response called a transient hyperemic response to carotid compression can also be employed [28]. In practice, however, these tests are rarely utilized in the inten­sive care unit.
Static autoregulation is measured using pharmacologic manipulation of blood pressure during continuous TCD monitoring. It is calculated as a percentage change in cerebrovascular reserve (CVR) / a percent change in CPP x 100. CVR is dened
8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
as CPP /mean TCD velocities Using this method, autoregulation is expressed as a percentage with 100% signifying intact autoregulation [29, 30].
CO2 vasoreactivity can similarly be addressed while measuring continuous TCD ow velocities during manipulation of PCO2. This can be achieved through breath holding or changes in inspired pCO2. Acetazolamide can similarly be used, but con­cerns have been raised using this pharmacology since acetazolamide may directly affect middle cerebral artery (MCA) diameter during testing and may complicate the calculation of changes in CBF [31].
153
8.6 TCD/TCCS: Use intheNeurological Critical Care Unit
8.6.1 TCD/TCCS: Use inSubarachnoid Hemorrhage
TCD can be used in the neuro ICU for a variety of neurological processes. It is most commonly used to detect the development of cerebral vasospasm after subarachnoid hemorrhage. Cerebral vasospasm is a self-limited vasculopathy that develops 4–14days after subarachnoid hemorrhage. Pathologically, the basal cerebral arter­ies develop a T-cell inltrate, collagen remodeling, and smooth muscle proliferation [32]. This can potentially lead to vessel narrowing and cerebral ischemia. Vasospasm appears to be a reaction to the amount and location of subarachnoid blood as rst described by Fisher [33] and later veried by Kistler [34].
Prior to the development of TCD, vasospasm could only be detected through the use of cerebral angiography. Aaslid was able to demonstrate, however, a good cor­relation between MCA ow velocities and actual vessel luminal diameter as mea­sured by angiography. Mean MCA ow velocities greater than 120cm/s represented mild narrowing, while ow velocities greater than 200cm/sec represented severe narrowing [1].
While TCD ow velocities can correlate with vessel narrowing, using TCD to predict which patients will develop subsequent cerebral ischemia has been more problematic. Initial studies suggested that absolute or rapid increases in ow veloci­ties were indicative of impending neurological decits [35, 36]. However, subse­quent studies could not reproduce these ndings [37].
The reasons for this discrepancy in ndings may be technical. TCD ow veloci­ties need to be corrected for a variety of physiological parameters [38] but in prac­tice rarely are. In an attempt to differentiate increased blood ow from vessel narrowing, Lindegaard developed a ratio of ow velocities from the extracranial carotid artery to the MCA.Elevated ow velocities in the MCA not matched in the extracranial internal carotid artery (ICA) would suggest vessel narrowing, while similar changes would suggest hyperemia [39]. Similar ratios have been developed for the posterior circulation [40]. Disturbances in cerebral autoregulation after sub­arachnoid hemorrhage can lead to a misinterpretation of TCD ow velocities. Manipulations of blood volume and blood pressure commonly employed for
154
E. M. Manno and F. Sorond
treatment of cerebral vasospasm can directly affect TCD ow velocities in patients with disturbed autoregulation [30]. Measurements of cerebral vascular reserve in patients with vessel narrowing may prove to be predictive of which patients are at risk for developing ischemic decits [41].
Finally, the premise that vessel narrowing is the source of cerebral ischemia after subarachnoid hemorrhage may be inaccurate. Recent speculations have suggested that the hemoglobin released into the subarachnoid space binds spinal uid nitrous oxide which is needed for vasomotor coupling of metabolism to CBF [42]. Rabinstein reported that most cerebral infarcts after subarachnoid hemorrhage occurred in vascular territories unaffected by vessel narrowing [43]. Similarly, the results of the Conscious-2 trial a randomized study of an endothelin receptor antag­onist reported signicant improvement in vessel narrowing after subarachnoid hem­orrhage with no effect on ischemic decits or outcome [44].
8.6.2 TCD/TCCS: Use After Traumatic Brain Injury (TBI)
TCD/TCCS has been used to facilitate management in the intensive care unit [45]. TCD use after TBI can be utilized to estimate intracranial pressure (ICP), determine the status of cerebral autoregulation, and determine if cerebral vasospasm.
Changes in TCD waveforms have been documented with increases in ICP.Loss of distal compliance leads to an increased pulsatility index. Continued increases lead to loss of diastolic ow velocities. At extreme levels, systolic spikes and loss of TCD waveforms are noted [46]. Pulsatility indexes have been correlated with ICP in a variety of cerebral conditions; however, attempts to dene ICP based on TCD/ TCCS waveform analysis have fallen short [47].
While TCD/TCCS waveforms as yet cannot be used to replace ICP, monitoring increases in pulsatility indexes can be used to potentially identify expanding lesions, focal or global increases in ICP, and decreases in CPP.Continuous TCD monitoring has noted an increase in pulsatility indexes in head trauma patients at their CPP dropped below 70mmHg, thus potentially providing a warning for inadequate per­fusion [48]. Flow velocities below 35cm/sec suggesting decreased CBF after head trauma have been associated with poor outcomes [48, 49]. Similarly, loss of cerebral autoregulation is common after head trauma and has been associated with worse outcomes. Identifying these disturbances early in the post-traumatic course may allow for individualized therapies [50, 51].
Traumatic subarachnoid hemorrhage is common, and cerebral vasospasm can develop in similar patterns as detected after aneurysmal subarachnoid hemorrhage. Cerebral vasospasm after head trauma has been identied as a predictor of poor outcome [52], and medical maneuvers designed to increase CBF can potentially be employed. Interestingly, posterior circulation vasospasm is more common after traumatic subarachnoid hemorrhage [53].
8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
155
8.6.3 TCD/TCCS: Conrmation ofBrain Death
TCD can be utilized as a conrmatory test to assess for the absence of CBF in patients that have met criteria for brain death. The portability of TCD allows for the assessment of hemodynamically unstable patients that may not tolerate transfer out­side of the intensive care unit. TCD use as a conrmation test has been reported to shorten the time of diagnosis.
Several patterns of waveforms have been described to indicate the absence of effective perfusion. These include small systolic spikes, oscillating ow, and loss of signal which had previously been isolated [54]. If vessels have not been previously insonated, the absence of signal cannot be utilized since in about 10% of patients’ vessels cannot be insonated through the temporal bone. Sensitivity increases with the number of vessels which can be isolated. A lower false-positive rate has been reported when using a transorbital approach [55].
A recent meta-analysis conrmed the diagnostic accuracy or TCD conrmation of brain death, and most countries accept TCD as an ancillary test to conrm brain death [56]. Consensus guidelines for the determination of circulatory arrest have been proposed by the World Federation of Neurology [57]. Despite this, Canada, Australia, and New Zealand prefer other methods for conrmation [58].
8.6.4 TCD/TCCS: Use inIntracerebral Hemorrhage
TCD use after intracerebral hemorrhage traditionally had limited value. Poorer out­comes have been noted in patients with disturbed cerebral autoregulation and CO2 vasoreactivity [59]. Differences in the middle cerebral artery pulsatility indexes may suggest side-to-side differentials in ICP.
Newer sonographic techniques have been used in the ICU to evaluate intracere­bral hemorrhages. Transcranial color-coded sonography has identied spontaneous hemorrhages [60]. Transcranial duplex sonography has identied midline shift after intracerebral hemorrhage and has been utilized to predict outcome after hemorrhage [61, 62].
8.6.5 TCD/TCCS: Other Uses intheIntensive Care Unit
A variety of information can be gathered during routine TCD evaluation. Evidence for midline shift or a different location of a vessel previously insonated can suggest the development of a mass lesion. High-intensity transient signals (HITS) suggest recurrent emboli which can be detected during transient ischemic attack evaluation
156
E. M. Manno and F. Sorond
or post-carotid endarterectomy [63]. Reversal or patency of vessels can be evaluated using TCD after bypass operations. Changes in vascular resistance can signify a local mass lesion or decreased perfusion. All may point to the need for additional imaging. More recently, increased continuous MCA ow velocities were noted dur­ing episodes of non-convulsive status epilepticus [64].

8.7 Conclusion

TCD/TCCS has gained increasing acceptance and use due to its many advantages of ease of use and access, cost, portability, and reliability. By measuring ow veloci­ties, both cerebral and CO2 vasoreactivity can be assessed providing valuable infor­mation to the neurological status of the patient. TCD, while unable to predict with condence which patients will develop ischemic complications after subarachnoid hemorrhage, is quite useful in identifying that cerebral vasospasm is developing. Subsequently, this can focus neurological assessments and treatments. It is a useful tool in several circumstances for conrming brain death in the hemodynamically unstable patient. Newer sonographic techniques have been developed that will offer promising new insights into both the pathogenesis and prognosis of a number of acute neurological conditions.

References

1. Aaslid R, Markwalder T-M, Nornes H.Noninvasive transcranial Doppler ultrasound recording
of ow velocity in basal cerebral arteries. J Neurosurg. 1982;57:769–74.
2. Fick A.Ueber die Messung des Blutquantums in den Herzventrikeln. Sitz ber Physik-Med Ges
Wurzburg. 1870;2:16–28.
3. Kety SS, Schmidt CF.The determination of cerebral blood ow in man by the use of nitrous
oxide in low concentrations. Am J Phys. 1945;143:53–66.
4. Manno EM, Koroshetz WJ. Cerebral blood ow. Chapter 5. In: Babikian VL, Wechsler LR,
editors. Transcranial Doppler ultrasonography. 2nd ed. Boston: Butterworth Heinmann; 1999. p.67–87.
5. Aaslid R.Development of the principles of transcranial Doppler ultrasound. In: Aaslid R,
Newell DE, editors. Transcranial Doppler. NewYork: Raven Press; 1992. p.1–8.
6. Saver JL, Feldmann E.Basic transcranial Doppler examinations. In: Babikian VL, Wechsler
LR, editors. Transcranial Doppler ultrasonography. Mosby-Year Book: St Louis; 1993. p.11–28.
7. Manno EM.Transcranial Doppler ultrasonography in the neurocritical care unit. In: Diringer
MN, editor. Critical care clinics, vol. 13. Philadelphia: W.B.Saunders; 1997. p.79–104.
8. Sorteberg W.Cerebral artery blood velocity and cerebral blood ow. In: Newell DW, Aaslid R,
editors. Transcranial Doppler. NewYork: Raven; 1992. p.57–66.
9. Sorteberg W, Lindegaard KF, Rootwell K, etal. Blood velocity and regional blood ow in
dened cerebral artery systems. Acta Neurochir. 1989;97:47–52.
10. Schoning M, Walter J, Scheel P.Estimation of cerebral blood ow through color duplex sonog-
raphy of the carotid and vertebral arteries in healthy adults. Stroke. 1994;25:17–22.
8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
11. Kirkham FJ, Padayachee TS, Parsons S, etal. Transcranial measurement of blood velocities
in the basal cerebral arteries using pulsed Doppler ultrasound: velocity as an index of ow. Ultrasound Med Biol. 1986;12:15–21.
12. Dahl A, Russell D, Nyberg-Hansen R, etal. Simultaneous assessment of vasoreactivity using
transcranial Doppler ultrasound and cerebral blood ow in healthy subjects. J Cereb Blood Flow Metab. 1994;14:974–81.
13. Sorteberg W, Lindegaard KF, Rootwell K, etal. Effect of acetazolamide on cerebral artery blood
velocity and regional cerebral blood ow in normal subjects. Acta Neurochir. 1989;97:47–52.
14. Naylor AR, Merrick MV, Slattery JM, etal. Parametric imaging of cerebrovascular reserve.
Eur J Nucl Med. 1991;18:259–64.
15. Kofke WA, Brauer P, Policare R, etal. Middle cerebral artery blood ow velocity and stable
xenon-enhanced computed blood ow during test balloon occlusion of the internal carotid artery. Stroke. 1995;26:1603–6.
16. Hartmann A, Ries F, Tsuda Y, et al. Correlation of regional cerebral blood ow and blood
ow velocity in normal volunteers and patients with cerebro-vascular disease. Neurochirgia (Stuttg). 1991;34:6–13.
17. Manno EM, Rabinstein AA.Central nervous system. Chapter 43. In: Gabriella A, Layton AJ,
Yu M, editors. Civetta, Taylor, and Kirby’s critical care. 4th ed. Philadelphia: Wolters Kluver Lippincott Williams and Wilkins; 2009. p.649–65.
18. Rose JC, Mayer SA.Optimizing blood pressure in neurological emergencies. Neurocrit Care.
2004;1:287–99.
19. Edvisson L.Neurogenic mechanisms in the cerebrovascular bed. Autonomic nerves, amine
receptors, and their effects on cerebral blood ow. Acta Physiol Scand Suppl. 1975;427:1.
20. Kontos HA, Wei EP, Navari RM, etal. Responses of cerebral arteries and arterioles to acute
hypotension and hypertension. Am J Physiol Heart Circ Physiol. 1978;234:H371.
21. Folkow B.Description of the myogenic hypothesis. Circ Res. 1964;15:279–87.
22. Chillon JM, Baumbach JL.Autoregulation: arterial and intracranial pressure. In: Edvisson L,
Krause DN, editors. Cerebral blood ow and metabolism. 2nd ed. Philadelphia: Lippincott Williams and Wilkens; 2002. p.395–412.
23. Lou HC, Edvission L, MacKenzie ET.The concept of coupling blood ow to brain function:
revision required? Ann Neurol. 1987;22:289.
24. Ginsberg MD.Cerebral circulation: its regulation, pharmacology, and pathophysiology. In:
Asbury AK, McKhann GM, McDonald WI, editors. Diseases of the nervous system clinical neurobiology. Philadelphia: Saunders; 1992. p.989–1001.
25. Harper AM, Glass HI.Effect of alterations in the arterial carbon dioxide tension on the blood
ow through the cerebral cortex at normal and low arterial pressures. J Neurol Neurosurg Psychiatry. 1965;28:449–52.
26. Ropper AH.Treatment of intracranial hypertension. In: Ropper AH, editor. Neurological and
neurosurgical intensive care. 3rd ed. NewYork: Raven Press; 1993. p.29–52.
27. Ringelstein EB, Otis SM. Physiological testing of vasomotor reserve. Chapter 8. In: Newell
DW, Aaslid R, editors. Transcranial Doppler. NewYork: Raven; 1992. p.83–100.
28. Aaslid R.Cerebral Hemodynamics chapter 5. In: Newell DW, Aaslid R, editors. Transcranial
Doppler. NewYork: Raven; 1992. p.49–55.
29. Tiecks FP, Lam AM, Aaslid R, Newell DW.Comparison of static and dynamic autoregulation
measurements. Stroke. 1995;26:1014–9.
30. Manno EM, Gress DR, Schwamm LH, et al. Effects of induced hypertension on transcra-
nial Doppler ultrasound velocities in patients after subarachnoid hemorrhage. Stroke. 1998;29:422–8.
31. Ringelstein EB, van Eyck S, Mertens I.Evaluation of cerebral vasomotor reactivity by vari-
ous vasodilating stimuli: comparison of CO2 with acetazolamide. J Cereb Blood Flow Metab. 1992;12:162–8.
32. Tresser SJ, Selmon WR, Ratcheson RA.Pathophysiological alterations following aneurysm
rupture. Concepts Neurosurg. 1994;6:23–45.
157
158
33. Fisher CM, Kistler JP, Davis JM.Relation of cerebral vasospasm to subarachnoid hemorrhage
visualized on computed tomographic scanning. Neurosurgery. 1980;6:1–9.
34. Kistler JP, Crowell RM, Davis KR, etal. The relation of cerebral vasospasm to the extent
and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology. 1983;33:424–36.
35. Seckhar LN, Wechsler LR, Yonas H, etal. Value of transcranial Doppler examination in the diag-
nosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1988;22:813–21.
36. Sloan MA, Rigamonti D, Rothman M, etal. Sensitivity and specicity of transcranial Doppler
ultrasound in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology. 1989;39:1514–8.
37. Laumer R, Steinmeier R, Gonner F, et al. Cerebral hemodynamics in subarachnoid hemor-
rhage evaluated by transcranial Doppler ultrasonography. Part 1: reliability of ow velocities in clinical management. Neurosurgery. 1993;33:1–9.
38. Brass LM, Pavlakis SG, DeVivo D, etal. Transcranial Doppler measurements of the middle
cerebral artery: effect of hematocrit. Stroke. 1988;19:1466–9.
39. Lindegaard KF, Nornes H, Bakke SJ, et al. Cerebral vasospasm after subarachnoid hemor-
rhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien). 1988;42:81–4.
40. Soustiel JF, Shik V, Schreiber R, etal. Basilar vasospasm diagnosis: investigation of a modied
“Lindegaard index” based on imaging studies and blood velocity measurements of the basilar artery. Stroke. 2002;33:72–7.
41. Hassler W, Chiof F.CO2 reactivity of cerebral vasospasm after aneursysmal subarachnoid
hemorrhage. Acta Neurochir. 1989;98:167–75.
42. Siuta M, Zuckerman SL, Mocco J.Nitric oxide in cerebral vasospasm. Theories measurement
and treatment. Neurology Research International; 2013;2013:11. Article ID 972417.
43. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF.Patterns of cerebral infarction in aneu-
rysmal subarachnoid hemorrhage. Stroke. 2005;36:992–7.
44. MacDonald RL, Higashida RT, Keller E, etal. Clazosentan, an endothelian receptor antagonist
in patients with subarachnoid hemorrhage undergoing surgical clipping: a randomized double blinded placebo controlled phase 3 trial (conscious 2). Lancet Neurol. 2011;10:618–25.
45. White H, Venkatesh B. Applications of transcranial Doppler in the ICU: a review. Intensive
Care Med. 2006;32:981–94.
46. Hassler W, Steinmetz H, Gawloswski J.Transcranial Doppler ultrasongraphy in raised intra-
cranial pressure and in circulatory arrest. J Neurosurg. 1988;68:745–51.
47. Klingelhofer J, Conrad B, Benecke R, etal. Evaluation of intracranial pressure from transcra-
nial Doppler studies in cerebral disease. J Neurol. 1988;235:159–62.
48. Chan K-H, Miller JD, Dearden NM. Intracranial blood ow velocity after head injury: rela-
tionship to severity of injury, time, neurological status, and outcome. J Neurol Neurosurg Psychiatry. 1992;55:787–91.
49. Van Santbrink H, Schouten JW, Steyerberg EW, etal. Serial transcranial Doppler measure-
ments in traumatic brain injury with special focus on the early posttraumatic period. Acta Neurochir. 2002;144:1141–9.
50. Vavilala MS, Lee LA, Boddu K, etal. Cerebral autoregulation in pediatric traumatic brain
injury. Pediatr Crit Care Med. 2004;5:257–63.
51. Schmidt EA, Czosnyka M, Steiner LA, etal. Asymmetry of pressure autoregulation after trau-
matic brain injury. J Neurosurg. 2003;99:991–8.
52. Compton JS, Teddy PJ.Cerebral arterial vasospasm following severe head injury: a transcra-
nial Doppler study. Br J Neurosurg. 1987;1:435–9.
53. Martin NA, Doberstein C, Zane C, et al. Posttraumatic cerebral arterial spasm: transcra-
nial Doppler ultrasound, cerebral blood ow, and angiographic ndings. J Neurosurg. 1992;77:575–83.
54. Azevedo E, Teixeira J, Neves JC, Vaz R.Transcranial Doppler and brain death. Transplant
Proc. 2000;32:2579–81.
E. M. Manno and F. Sorond
8 Transcranial Doppler (TCD/TCCS) and Cerebral Blood Flow: Applications…
55. Dominguez-Roldan JM, Jimenez-Gonzalez PI, Garcia-Alfaro C, etal. Diagnosis of brain death
by transcranial Doppler sonography: solutions for cases of difcult sonic windows. Transplant Proc. 2004;36:2896–7.
56. Chang JJ, Tsivgoulis G, Katsanos AH, etal. Diagnostic accuracy of transcranial Doppler for
brain death conrmation: systemic review and meta-analysis. AJNR. 2016;37:408–14.
57. Ducrocq X, Hassler W, Moritake K, etal. Consensus opinion on diagnosis of cerebral circula-
tory arrest using Doppler-sonography: task force group on cerebral death of the neurosonology research group of the World Federation of Neurology. J Neurol Sci. 1998;159:145–50.
58. Young GB, Shemie SD, Doig J, Teitelbaum JT.Brief review: the role of ancillary tests in the
neurological determination of death. Can J Anesth. 2006;53:620–7.
59. Klingelhofer J, Sander D.Doppler CO2 test as an indicator of cerebral vasoreactivity and
prognosis in severe intracerebral hemorrhage. Stroke. 1992;23:962–6.
60. Kukulska-Pawluczul B, Ksiazkiewicz B, Nowaczewska M. Imaging of spontaneous intra-
cerebralhemorrhages by means of transcranial colr-coded sonography. Europ J Radiol. 2012;81:1253–8.
61. Kiphuth IC, Huttmer HB, Breuer L, etal. Songraphic monitoring of midline shift predicts
outcome after intracerebral hemorrhage. Cerebrovascular Dis. 2012;34:297–304.
62. Camps-Renom P, Granell JME, Prats-Sanchez L, etal. Transcranial duplex sonography pre-
dicts outcome following intracerebral hemorrhage. AJNR. 2017;38:1543–9.
63. Spencer MP, Thomas GI, Nicholls SC, Sauvage LR.Detection of middle cerebral emboli dur-
ing carotid endarterectomy using transcranial doppler ultrasound. Stroke. 1990;21:415–23.
64. Merceron S, Geeraerts T, Montlahuc C, etal. Assessment of cerebral blood ow in nonconvul-
sive status epilepticus in comatose patients: a pathophysiological transcranial Doppler study. Seizure. 2014;23:284–9.
159
Part III
Neurosonology: Neurocritical Care Patient